Navigation Links
Prostate-specific antigen screening: Values and techniques shape decisions
Date:2/11/2013

CHAPEL HILL, N.C. - What's most important to a man as he decides whether or not to undergo prostate-specific antigen- PSA- screening for prostate cancer? What does he value most about the screening? And what's the best way to present the information to help him make an appropriate decision for himself?

An international team of scientists led by the University of North Carolina has published a study evaluating different ways of helping men consider their values about PSA screening. They report that the decision-making process was influenced by the format in which information was presented.

Their results were reported in the Feb. 11, 2013 online edition of the journal JAMA Internal Medicine.

Michael Pignone, MD, MPH, study senior author, says, "Whether to undergo PSA screening is a difficult decision for middle-aged men. PSA screening at best seems to produce only a small reduction in prostate cancer deaths and has considerable downsides.

"Effective prostate cancer screening aids should promote understanding of the benefits and risks involved in deciding whether or not to be screened and should incorporate patient values. Our study evaluated different values clarification methods to determine if there is a difference in men's decision-making based on how they are asked to think about what factors matter to them. We found that there is a difference, and our findings pave the way for further studies."

Dr. Pignone is professor of medicine and chief of the division of general internal medicine, senior research fellow and co-director of the program on medical practice and prevention for the Cecil Sheps Center for Health Services Research, and a member of UNC Lineberger Comprehensive Cancer Center.

The team described PSA screening decision options in terms of four key attributes: effect on prostate cancer mortality, risk of biopsy, risk of being diagnosed with prostate cancer and risk of becoming impotent or incontinent as a result of treatment.

These attributes were presented in three different formats. The balance sheet was a table of relevant features of PSA screening, and participants were asked to consider this information as they saw fit; in the second format, participants were asked to rate and rank the four attributes; in the third group, participants considered a series of hypothetical choices made up of different levels of these attributes.

The study involved 911 men ages 50 to 70 from the United States and Australia at average risk of developing prostate cancer. They were asked to complete questionnaires before and after value clarification.

Men who completed the balance sheet option where PSA screening versus no screening options were labeled most often chose the screening option: 43.7 percent. Men who completed the two unlabeled rate and rank and hypothetical choices surveys where the options were not labeled PSA screening or no screening were less likely to choose the screening option: 34.2 percent for the rate and rankings, 20.2 percent for the hypotheticals.

Dr. Pignone says, "What we learned was that how screening information is presented makes a difference in how men view the relative importance of different features of the decision. What this means is that more studies must be completed to determine the best method of value clarification around decision making for PSA screening."


'/>"/>

Contact: Dianne Shaw
dgs@med.unc.edu
919-966-7834
University of North Carolina Health Care
Source:Eurekalert

Related medicine news :

1. Study: Vaccine targets malignant brain cancer antigens, significantly lengthens survival
2. Cancer screening: The efficacy of mammography screening
3. Women With Dense Breasts Open to Additional Cancer Screening: Study
4. Mayo Clinic expert suggests proper techniques for newborn bathing and skin care basics
5. Revolutionary techniques could help harness patients own immune cells to fight disease
6. Improved techniques may help recovery and prevent incidents of missing drivers with dementia
7. Flu outbreaks predicted with weather forecast techniques
8. New tools and techniques enhance laparoscopic gallbladder removal
9. New Techniques May Improve Infant Heart Surgery
10. Skechers Lawsuit on Behalf an Ohio Woman Who Sustained Serious Ankle Injury Allegedly Due to Shape-Ups' Defective Design Filed by Wright & Schulte LLC
11. Skechers Lawsuit Filed by Wright & Schulte, Utah Plaintiff Allegedly Suffered Serious Ankle Injuries Due to Shape-Ups Defective Design
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: